Literature DB >> 5925910

Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.

B F Felsher, A G Redeker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5925910     DOI： 10.1097/00005792-196645060-00024

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  6 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.

Authors:  Joshi Poorvashree; Dhaneshwar Suneela
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

3.  Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda.

Authors:  A C Liu
Journal:  West J Med       Date:  1995-06

4.  Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.

Authors:  H Salameh; H Sarairah; M Rizwan; Y-F Kuo; K E Anderson; A K Singal
Journal:  Br J Dermatol       Date:  2018-07-26       Impact factor: 9.302

5.  [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].

Authors:  G Goerz; T Krieg; M G Eichenauer
Journal:  Arch Dermatol Res       Date:  1976-04-21       Impact factor: 3.017

6.  Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.

Authors:  Ashwani K Singal; Csilla Kormos-Hallberg; Chul Lee; Vaithamanithi M Sadagoparamanujam; James J Grady; Daniel H Freeman; Karl E Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.